ProtAffin AG, a biotechnology company developing a novel class of next-generation biopharmaceuticals for respiratory disease, inflammation and oncology, today announced that it has started dosing healthy volunteers in a Phase 1 clinical study in the UK with its novel investigational anti-inflammatory product, PA401.
29 June, 2012
The Association of the British Pharmaceutical Industry (ABPI), the BioIndustry Association (BIA) and the Clinical Contract Research Association (CCRA) have today jointly published guidance on insurance and compensation for Phase I clinical trials.
28 June, 2012
A commonly prescribed diabetes drug, metformin, reduces the overall cancer risk in people with Type 2 diabetes, a large systematic review study finds.
26 June, 2012
Researchers studying the genetic roots of the most common malignant childhood brain tumor have discovered missteps in three of the four subtypes of the cancer that involve genes already targeted for drug development. The work was published on the online issue of the scientific journal Nature.
21 June, 2012
In spite of the progress made in pharmaceutical research, the drug discovery and development process remains both time-consuming and expensive, with only one of thousands of potential lead molecules investigated becoming a marketed drug.
21 June, 2012
Waters® Corporation held a groundbreaking ceremony for its new Mass Spectrometry Headquarters planned for completion in 2014.
20 June, 2012
The University of Cambridge is embarking on a programme of scientific open collaboration with GlaxoSmithKline (GSK) that will involve working alongside GSK scientists and other partner organizations, to advance drug discovery and the development of new medicines.
19 June, 2012
The fight against cancer is leading a new movement in gene therapy, as the failure of conventional cancer therapies is fuelling demand for new treatments, according to a new report by healthcare experts GBI Research.
18 June, 2012
A recent placebo-controlled study reveals new evidence of trans-cranial bright light's effect to brain functions when administered through the ear. The new research findings from Finland were published in the World Journal of Neuroscience.
15 June, 2012
On the occasion of World Anti-Counterfeiting Day, EAEPC, EFPIA, GIRP and PGEU are pleased to announce significant progress on their proposed European Stakeholder Model (ESM), a European medicines verification project aimed at preventing falsified medicines from entering the European supply chain and improving patient safety.
13 June, 2012
The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.
11 June, 2012
Preclinical results published in the Journal of Hormone Molecular Biology and Clinical Investigation Estetrol proven to have an estrogen antagonistic effect on breast tumour tissue.
07 June, 2012
The Government is too focused on encouraging ‘breakthrough drugs’ at the expense of significant gains for patients from incremental innovation in medicines, warned Stephen Whitehead, Chief Executive of the ABPI. Stephen Whitehead warned that this approach threatens the future of pharmaceutical medical research in the UK.
06 June, 2012
Bristol-Myers Squibb Company today announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the scientific understanding of immuno-oncology.
01 June, 2012